{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:31:37Z","timestamp":1793604697148,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.contraception.2023.110310","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:58:57Z","timestamp":1697630337000},"page":"110310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Comparison of estrogenic components used for hormonal contraception"],"prefix":"10.1016","volume":"130","author":[{"given":"Frank Z.","family":"Stanczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2023.110310_bib1","first-page":"170","article-title":"The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?","volume":"150","author":"Speroff","year":"1982","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.contraception.2023.110310_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1471-0528.1985.tb02994.x","article-title":"Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception","volume":"92","author":"Tayob","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2023.110310_bib3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0015-0282(16)54245-9","article-title":"Characteristics of ovarian follicular development in Norplant users","volume":"55","author":"Shoupe","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2023.110310_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-020-00557-5","article-title":"Hormonal contraceptives and dermatology","volume":"22","author":"Williams","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.contraception.2023.110310_bib5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.fertnstert.2016.08.039","article-title":"Hormonal contraception and thrombosis","volume":"106","author":"Sitruk-Ware","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2023.110310_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"\u00c5gren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2023.110310_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OAJC.S204655","article-title":"Contraception with estradiol valerate and dienogest: adherence to the method","volume":"10","author":"Fruzzetti","year":"2019","journal-title":"Open Access J Contracept"},{"key":"10.1016\/j.contraception.2023.110310_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13625187.2022.2093850","article-title":"A novel estetrol-containing combined oral contraceptive: European expert panel review","volume":"27","author":"Gemzell-Danielsson","year":"2022","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2023.110310_bib9","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.3390\/jcm11154634","article-title":"Bleeding patterns of oral contraceptives with a cyclic dosing regimen: an overview","volume":"11","author":"Archer","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.contraception.2023.110310_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2022.07.010","article-title":"Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol\/drospirenone on bleeding patterns in healthy women","volume":"116","author":"Kaunitz","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106359","article-title":"Biosynthesis of estetrol in human pregnancy: Potential pathways","volume":"232","author":"Stanczyk","year":"2023","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl A","key":"10.1016\/j.contraception.2023.110310_bib12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.genm.2008.03.003","article-title":"Estrogen receptors in the kidney: lessons from genetically altered mice","volume":"5","author":"Lane","year":"2008","journal-title":"Gend Med"},{"key":"10.1016\/j.contraception.2023.110310_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.brainresrev.2007.05.013","article-title":"Estrogen receptor beta in the brain: from form to function","volume":"57","author":"Weiser","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.contraception.2023.110310_bib14","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1210\/en.2006-0113","article-title":"Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding","volume":"147","author":"Zhu","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2023.110310_bib15","doi-asserted-by":"crossref","first-page":"24353","DOI":"10.1074\/jbc.M201829200","article-title":"Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression","volume":"277","author":"Liu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.contraception.2023.110310_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mi.3.5.281","article-title":"Estrogen signaling: a subtle balance between ER alpha and ER beta","volume":"3","author":"Matthews","year":"2003","journal-title":"Mol Interv"},{"key":"10.1016\/j.contraception.2023.110310_bib17","first-page":"1370","article-title":"Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium","volume":"86","author":"Critchley","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2023.110310_bib18","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.15252\/emmm.201404112","article-title":"The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor \u03b1 modulation, uncoupling nuclear and membrane activation","volume":"6","author":"Abot","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.contraception.2023.110310_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"G\u00e9rard","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.contraception.2023.110310_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110310_bib21","series-title":"Clinical gyneologic endocrinology and infertility","first-page":"691","author":"Speroff","year":"2005"},{"key":"10.1016\/j.contraception.2023.110310_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2006.04.005","article-title":"Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins","volume":"74","author":"White","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib24","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1210\/jc.2005-0352","article-title":"Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy","volume":"90","author":"Ropponen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.contraception.2023.110310_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"Douxfils","year":"2020","journal-title":"Contraception"},{"issue":"Pt A","key":"10.1016\/j.contraception.2023.110310_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.steroids.2014.08.006","article-title":"Mechanisms of estrogen carcinogenesis: the role of E2\/E1-quinone metabolites suggests new approaches to preventive intervention--A review","volume":"99","author":"Yager","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2023.110310_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1389557515666150226121052","article-title":"Role of 2-methoxyestradiol, an endogenous estrogen metabolite, in health and disease","volume":"15","author":"Parada-Bustamante","year":"2015","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.contraception.2023.110310_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/carcin\/19.1.1","article-title":"Functional role of estrogen metabolism in target cells: review and perspectives","volume":"19","author":"Zhu","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.contraception.2023.110310_bib29","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1073\/pnas.85.21.7831","article-title":"Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization","volume":"85","author":"Swaneck","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.contraception.2023.110310_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jcem-51-3-611","article-title":"Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology","volume":"51","author":"Fishman","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2023.110310_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0022-4731(89)90380-4","article-title":"Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers","volume":"32","author":"Van Aswegen","year":"1989","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2023.110310_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.1995.tb12113.x","article-title":"The role of estrogen in mammary carcinogenesis","volume":"768","author":"Fishman","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 7","key":"10.1016\/j.contraception.2023.110310_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1289\/ehp.95103s7147","article-title":"Effects of pesticides on the ratio of 16 alpha\/2-hydroxyestrone: a biologic marker of breast cancer risk","volume":"103","author":"Bradlow","year":"1995","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.contraception.2023.110310_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105685","article-title":"The 2-\/16\u03b1-hydroxylated estrogen ratio-breast cancer risk hypothesis: insufficient evidence for its support","volume":"201","author":"Stanczyk","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2023.110310_bib35","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0024-3205(90)90431-P","article-title":"Metabolism of 17 alpha-ethynylestradiol in humans","volume":"47","author":"Guengerich","year":"1990","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2023.110310_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13697130802056511","article-title":"First human exposure to exogenous single-dose oral estetrol in early postmenopausal women","volume":"11","author":"Visser","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2023.110310_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-198308020-00001","article-title":"Clinical pharmacokinetics of oral contraceptive steroids","volume":"8","author":"Orme","year":"1983","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2023.110310_bib38","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0022-4731(85)90068-8","article-title":"The metabolism of estradiol; oral compared to intravenous administration","volume":"23","author":"Longcope","year":"1985","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2023.110310_bib39","article-title":"The free hormone hypothesis: when, why, and how to measure the free hormone levels to assess vitamin D, thyroid, sex hormone, and cortisol status","volume":"5","author":"Bikle","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/j.contraception.2023.110310_bib40","first-page":"457","article-title":"The serum transport of steroid hormones","volume":"38","author":"Siiteri","year":"1982","journal-title":"Recent Prog Horm Res"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2023.110310_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/13697130701851814","article-title":"Estetrol does not bind sex hormone binding globulin or increase its production by human HepG2 cells","volume":"11","author":"Hammond","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2023.110310_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0163-7258(89)90121-6","article-title":"Interindividual variation in the metabolism of ethynylestradiol","volume":"43","author":"Orme","year":"1989","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.contraception.2023.110310_bib43","series-title":"Estrogens and antiestrogens II","first-page":"261","article-title":"Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens","author":"Kuhnz","year":"1999"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2023.110310_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13697130802073425","article-title":"Estetrol review: profile and potential clinical applications","volume":"11","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.contraception.2023.110310_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/09513599509160463","article-title":"The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth","volume":"9","author":"Teichmann","year":"1995","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2023.110310_bib46","doi-asserted-by":"crossref","first-page":"e3008","DOI":"10.1210\/clinem\/dgac150","article-title":"Estradiol Valerate vs ethinylestradiol in combined oral contraceptives: effects on the pituitary-ovarian axis","volume":"107","author":"Haverinen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2023.110310_bib47","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.contraception.2021.03.003","article-title":"Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function","volume":"103","author":"Duijkers","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib49","first-page":"CD003989","article-title":"20 \u00b5g versus >20 \u00b5g estrogen combined oral contraceptives for contraception","volume":"2013","author":"Gallo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2023.110310_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/AOG.0b013e3182a1741c","article-title":"Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive","volume":"122","author":"Archer","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110310_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2009.08.010","article-title":"Review of clinical experience with estradiol in combined oral contraceptives","volume":"81","author":"Fruzzetti","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib52","first-page":"2093","article-title":"Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2","volume":"15","author":"Yang","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.contraception.2023.110310_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.maturitas.2007.02.022","article-title":"Endometrial bleeding during hormone therapy: the effect of progestogens","volume":"57","author":"Archer","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2023.110310_bib54","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3109\/09513590.2011.588848","article-title":"Vascular dysfunction as a cause of endometrial bleeding","volume":"28","author":"Archer","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2023.110310_bib55","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/jwh.2013.4320","article-title":"Efficacy and safety of a combined oral contraceptive containing estradiol valerate\/dienogest: results from a clinical study conducted in North America","volume":"23","author":"Nelson","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.contraception.2023.110310_bib56","unstructured":"Center for Drug Evaluation and Research; Food and Drug Administration. Clinical Review Estradiol Valerate\/Dienogest (NDA 22\u2013252). 28 April 2010. Available at: \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022252_orig-1_medr.pdf\u3009 (accessed March 3, 23)."},{"key":"10.1016\/j.contraception.2023.110310_bib57","unstructured":"Australian Government, Department of Health and Ageing; Therapeutic Goods Administration. Australian Public Assessment Report for Nomegestrol Acetate\/Oestradiol. October 2011. Available at: \u3008https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-zoely.pdf\u3009 (accessed March 3, 23)."},{"key":"10.1016\/j.contraception.2023.110310_bib58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.contraception.2016.12.001","article-title":"Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate\/17\u03b2-estradiol and drospirenone\/ethinyl estradiol on bleeding patterns in healthy women","volume":"95","author":"Mansour","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"\u00c5gren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2023.110310_bib60","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate\/17\u03b2-estradiol, compared with those of levonorgestrel\/ethinyl estradiol. A double-blind, randomised study","volume":"105","author":"Gaussem","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2023.110310_bib61","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/11590220-000000000-00000","article-title":"Metabolic and haemostatic effects of estradiol valerate\/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study","volume":"31","author":"Junge","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2023.110310_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"Douxfils","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.contraception.2023.110310_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/clinem\/dgac511","article-title":"Low thrombin generation in users of a contraceptive containing estetrol and drospirenone","volume":"108","author":"Morimont","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2023.110310_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study.","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib66","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2023.110310_bib67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2023.110310_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.21059","article-title":"Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use","volume":"83","author":"Pomp","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.contraception.2023.110310_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/107602960401000308","article-title":"Effect of age on oral contraceptive-induced venous thrombosis","volume":"10","author":"Girolami","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.contraception.2023.110310_bib71","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2023.110310_bib72","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2023.110310_bib73","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2023.110310_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2023.110310_bib75","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib76","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","article-title":"Recurrent use of newer oral contraceptives and the risk of venous thromboembolism","volume":"15","author":"Suissa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2023.110310_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2023.110310_bib78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(98)00002-X","article-title":"The risks of venous thromboembolic disease among German women using oral contraceptives: a database study","volume":"57","author":"Farmer","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110310_bib79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1783\/147118910793048665","article-title":"50 years of \"The Pill\": celebrating a golden anniversary","volume":"36","author":"Szarewski","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2023.110310_bib80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OAJC.S50693","article-title":"Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol","volume":"4","author":"Jensen","year":"2013","journal-title":"Open Access J Contracept"},{"key":"10.1016\/j.contraception.2023.110310_bib81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13625187.2021.1987410","article-title":"Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17\u03b2-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism","volume":"26","author":"Reed","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2023.110310_bib82","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"Heikinheimo","year":"2022","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078242300416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078242300416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:12:49Z","timestamp":1762117969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078242300416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":82,"alternative-id":["S001078242300416X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110310","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of estrogenic components used for hormonal contraception","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110310"}}